The product he suggests through The Ultimate Human is a CJC-1295 7.5 mg + Ipamorelin 15 mg injectable blend via Peptual
Review Article: Clinical Implications of Enteric and central D2 Receptor Blockade by Antidopaminergic Gastrointestinal Prokinetics
Patients often report: Reduction in bloating and abdominal pain within 2-3 weeks Improved bowel movement regularity by week 4-6 Enhanced tolerance to previously problematic foods by week 8-12 Reduced systemic inflammation (measured by CRP, ESR) after 12 weeks of consistent use BPC-157 for Musculoskeletal Healing: Tendons, Ligaments, and Joints For musculoskeletal applications, BPC-157 is typically administered via subcutaneous injection near the injury site
A 2008 follow-up in Inflammation Research characterized early functional recovery (days 14 post-transection) using the Achilles Functional Index, myeloperoxidase activity, and vascular index, and reported anti-inflammatory effects together with increased new vessel formation (Krivic et al., 2008)
It has been used for years in horses and dogs
Bulletin of Experimental Biology and Medicine